InterSEPT: In-Tunnel SeptRx European PFO Trial

NCT01385670 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Foramen Ovale, Patent
Heart Defects, Congenital
Heart Septal Defects

Interventions

DEVICE: Transcatheter PFO closure with the SeptRx Intrapocket PFO Occluder (IPO)

Sponsor

SeptRx, Inc.